Style | Citing Format |
---|---|
MLA | Gharaati M, et al.. "Evaluation of Rehacom Cognitive Rehabilitation on Different Aspects of Visual Attention in Patients With Middle Cerebral Artery Ischemia: A Nonblinded Randomized Clinical Trial." ARYA Atherosclerosis, vol. 20, no. 4, 2024, pp. 23-31. |
APA | Gharaati M, Hassaniabharian P, Saadatnia M, Zarrindast MR (2024). Evaluation of Rehacom Cognitive Rehabilitation on Different Aspects of Visual Attention in Patients With Middle Cerebral Artery Ischemia: A Nonblinded Randomized Clinical Trial. ARYA Atherosclerosis, 20(4), 23-31. |
Chicago | Gharaati M, Hassaniabharian P, Saadatnia M, Zarrindast MR. "Evaluation of Rehacom Cognitive Rehabilitation on Different Aspects of Visual Attention in Patients With Middle Cerebral Artery Ischemia: A Nonblinded Randomized Clinical Trial." ARYA Atherosclerosis 20, no. 4 (2024): 23-31. |
Harvard | Gharaati M et al. (2024) 'Evaluation of Rehacom Cognitive Rehabilitation on Different Aspects of Visual Attention in Patients With Middle Cerebral Artery Ischemia: A Nonblinded Randomized Clinical Trial', ARYA Atherosclerosis, 20(4), pp. 23-31. |
Vancouver | Gharaati M, Hassaniabharian P, Saadatnia M, Zarrindast MR. Evaluation of Rehacom Cognitive Rehabilitation on Different Aspects of Visual Attention in Patients With Middle Cerebral Artery Ischemia: A Nonblinded Randomized Clinical Trial. ARYA Atherosclerosis. 2024;20(4):23-31. |
BibTex | @article{ author = {Gharaati M and Hassaniabharian P and Saadatnia M and Zarrindast MR}, title = {Evaluation of Rehacom Cognitive Rehabilitation on Different Aspects of Visual Attention in Patients With Middle Cerebral Artery Ischemia: A Nonblinded Randomized Clinical Trial}, journal = {ARYA Atherosclerosis}, volume = {20}, number = {4}, pages = {23-31}, year = {2024} } |
RIS | TY - JOUR AU - Gharaati M AU - Hassaniabharian P AU - Saadatnia M AU - Zarrindast MR TI - Evaluation of Rehacom Cognitive Rehabilitation on Different Aspects of Visual Attention in Patients With Middle Cerebral Artery Ischemia: A Nonblinded Randomized Clinical Trial JO - ARYA Atherosclerosis VL - 20 IS - 4 SP - 23 EP - 31 PY - 2024 ER - |